ANNALS OF SURGICAL ONCOLOGY

Prognostic Significance of Recurrence and Timing of Recurrence on Survival Among Patients with Early-Stage Hepatocellular Carcinoma in U.S. Clinical Practice
Maithel SK, Wang R, Harton J, Yopp A, Shah SA, Rocha FG, Hernandez S, Cheng S, Ogale S and Tan R
Many patients with hepatocellular carcinoma (HCC) experience recurrence after curative-intent resection or ablation, with a poor prognosis. Real-world patterns of recurrence and the prognostic significance of early recurrence in U.S. clinical practice have not been well characterized.
Correction: Effect of Early Postoperative Mobilization on Functional Recovery, Hospital Length of Stay, and Postoperative Complications After Immediate Internal Pudendal Artery Perforator Flap Reconstruction for Irradiated Abdominoperineal Resection Defects: A Prospective, Randomized Controlled Trial
Lima de Araujo CA, de Freitas Busnardo F, Thome Grillo VA, Chirnev Felício CH, Antônia de Almeida LA, Sparapan Marques CF, Nahas CS, Imperialle AR, Cutait de Castro Cotti G, Gemperli R and Ribeiro U
ASO Author Reflections: Clinical Relevance of Mitochondrial Status in Patients with Esophageal Squamous Cell Carcinoma
Sugawara K, Sakashita S and Motoi N
ASO Visual Abstract: Essential Elements in Synoptic Operative Reports for Hepato-Pancreato-Biliary Cancer Surgery-An HPB/CGSO Training Program Survey
Kone LB, Seok D, Kimble MM, Maker AV, Patil S, Mittal V and Jacobs M
Invited Editorial About: "Impact of Tumoral β2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer," by C. Komine et al
Patel DD and Dickson PV
Fibroblast Activation Protein-α Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregulation to Adverse Survival in Colorectal Cancer
Qin Y, Miyake T, Muramoto K, Maekawa T, Nishina Y, Wang Y, Shimizu T and Tani M
Cancer-associated fibroblasts (CAFs) and immune cells, the key components of the tumor microenvironment (TME), play critical roles in oncogenesis. Despite the recognized function of fibroblast activation protein-α (FAP), a specific biomarker of CAFs in cancer progression, its role in the survival of patients with colorectal cancer (CRC) and tumor immune microenvironment (TIME) remains unclear.
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03
Cabioglu N, Karanlik H, Igci A, Muslumanoglu M, Gulcelik MA, Uras C, Kocer HB, Trabulus DC, Ozkurt E, Cakmak GK, Tukenmez M, Bademler S, Yildirim N, Akgul GG, Sen E, Senol K, Emiroglu S, Citgez B, Ersoy YE, Dag A, Zengel B, Basaran G, Kara H, Dilege E, Ugurlu MU, Celik A, Ilgun S, Bolukbasi Y, Karaman N, Sakman G, Ozbas S, Kilic HG, Polat AK, Ozemir IA, Kilic B, Altınok A, Varol E, Dogan L, Akcan A, Ozcinar B, Zer L, Soyder A, Velidedeoglu M, Erozgen F, Goktepe B, Dogan M, Kebudi A, Yigit B, Celik B, Yormaz S, Arici C, Agcaoglu O, Sevinc AI, Atahan MK, Valiyeva V, Baran E, Aljorani I, Utkan Z, Yeniay L, Kivilcim T, Soran A, Aydiner A, Ibis K and Ozmen V
This study aims to identify factors predicting recurrence and unfavorable prognosis in cN+ patients who have undergone sentinel lymph node biopsy (SLNB) following neoadjuvant chemotherapy (NAC).
A Multicenter Retrospective Study on Adjuvant S-1 Chemotherapy Versus Observation Following Major Hepatectomy for Perihilar Cholangiocarcinoma
Hosokawa I, Higuchi R, Homma Y, Takayashiki T, Ome Y, Matsuyama R, Takano S, Uemura S, Yabushita Y, Honda G, Endo I and Ohtsuka M
The prognosis of perihilar cholangiocarcinoma (PHC) is poor even after curative resection, highlighting the need for effective adjuvant chemotherapy. The efficacy of adjuvant S-1 chemotherapy following major hepatectomy for PHC is unclear, and thus the aim of this study was to elucidate this.
ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response to Neoadjuvant Therapy in HER2+ Early-Stage Breast Cancer
Winer LK and Williams AD
Patterns of Care and Oncologic Outcomes after Pelvic Exenteration for Locally Advanced Rectal Cancer in the United States
Troester A, Weaver L, Mott SL, Welton L, Jahansouz C, Hassan I and Goffredo P
Pelvic exenterations (PEs) are technically demanding procedures performed with curative intent for advanced malignancies to improve patient survival while balancing morbidity and functional outcomes. The majority of United States (US) data regarding PE for rectal cancers originate from single-center series.
Technical Guidelines for Safe Mesojejunum Dissection During Pancreaticoduodenectomy: Unveiling Critical Techniques in a Complex Procedure
Irie S, Inoue Y, Oba A, Ono Y, Sato T, Mise Y, Ito H, Saiura A and Takahashi Y
Pancreaticoduodenectomy (PD) is a complex procedure involving the dissection of the superior mesenteric artery and vein. However, a safe and standardized technique for dissecting the jejunal veins (JVs) in the mesojejunum during PD remains elusive.
ASO Author Reflections: Impact of PIPAC-Oxaliplatin on Functional Recovery, Quality of Life, Good Days, and Survival in Refractory Colorectal and Appendiceal Carcinomatosis
Waheed MT, Ruel N, Dellinger TH and Raoof M
ASO Author Reflections: Prognostic Value of NCCN Criteria for Resection Following Neoadjuvant Therapy in Localized Pancreatic Cancer
Jang JK, Byun JH, Choi SJ, Kim JH, Lee SS, Kim HJ, Yoo C, Kim KP, Hong SM, Seo DW, Hwang DW and Kim SC
ASO Visual Abstract: An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer
Liu D, Chen Z, Deng W, Lan J, Zhu Y, Wang H, Xu X, Zhang Y, Wu X, Yang K and Cai J
ASO Author Reflections: The Present and Future of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE)
Kooij CD, Ruurda JP and van Hillegersberg R
ASO Visual Abstract: Effect of Minimally Invasive Gastrectomy on Return to Intended Oncologic Therapy for Gastric Cancer
Koo A, Mavani PT, Sok C, Goyal S, Concors S, Mason MC, Winer JH, Russell MC, Cardona K, Lin E, Maithel SK, Kooby DA, Staley CA and Shah MM
ASO Visual Abstract: The Current State of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE)-Outcomes from the Upper GI International Robotic Association (UGIRA) Esophageal Registry
Kooij CD, de Jongh C, Kingma BF, van Berge Henegouwen MI, Gisbertz SS, Chao YK, Chiu PW, Rouanet P, Mourregot A, Immanuel A, Mala T, van Boxel GI, Carter NC, Li H, Fuchs HF, Bruns CJ, Giacopuzzi S, Kalff JC, Hölzen JP, Juratli MA, Benedix F, Lorenz E, Egberts JH, Haveman JW, van Etten B, Müller BP, Grimminger PP, Berlth F, Piessen G, van den Berg JW, Milone M, Luketich JD, Sarkaria IS, Sallum RAA, van Det MJ, Kouwenhoven EA, Brüwer M, Harustiak T, Kinoshita T, Fujita T, Daiko H, Li Z, Ruurda JP, van Hillegersberg R and
ASO Author Reflections: Improving the Quality of Cancer Care: Surgical Standards Version 1.0
Sample JW and Hieken TJ
Prehabilitation Outcomes in Surgical Oncology Patients Undergoing Major Abdominal Surgery: A Meta-analysis of Randomized Control Trials
Soh NH, Yau CRZ, Low XZ, Kadir HA, Fong WJ, Ramalingam MB, Tan PL, Ng KYY, Hsing YT, Cai M, Seo CJ, Ong JC, Chia CS and Wong JSM
Prehabilitation has been increasingly utilized to optimize perioperative outcomes. In this study, we aim to evaluate the impact of uni- and multimodal prehabilitation on functional capacity and postoperative outcomes among surgical oncology patients undergoing major abdominal surgery.
ASO Author Reflections: Tumor Spread Through Air Spaces Predicts Survival in Resected Pulmonary Lymphoepithelial Carcinoma
Chen PH, Chen C, Lu CW, Lu TP, Lee YH, Hsieh MS, Hsu HH and Chen JS
ASO Author Reflections: Immediate Breast Reconstruction After Mastectomy
Heeling E, Kramer GM, Volders JH and Vrancken Peeters MTFD